Related Experiment Video

Updated: Aug 21, 2026

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
09:40

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation

Published on: June 27, 2017

Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3

Mark C Wilkes1, Stephen J Murphy, Nandor Garamszegi

  • 1Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, and Mayo Clinic Cancer Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

Molecular and Cellular Biology
|November 13, 2003
PubMed

Insights

Transforming growth factor beta (TGF-beta) activates PAK2 in fibroblasts but not epithelial cells. This novel Smad-independent pathway explains TGF-beta

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Signal Transduction

Background:

  • Transforming growth factor beta (TGF-beta) induces distinct cellular responses, including growth arrest in epithelial cells and proliferation in fibroblasts.
  • Despite varied cellular outcomes, differences in TGF-beta signaling pathways between cell types were not well-defined, with the Smad cascade appearing universally controlled.
  • Understanding cell-type-specific TGF-beta signaling is crucial for deciphering its diverse biological roles.

Purpose of the Study:

  • To investigate potential Smad-independent pathways mediating differential TGF-beta responses in mammalian cells.
  • To identify novel molecular mechanisms distinguishing TGF-beta signaling in fibroblasts versus epithelial cells.

Main Methods:

  • Analysis of TGF-beta receptor signaling activation of STE20 homolog PAK2 in mammalian cell cultures.
  • Assessment of PAK2 activation in fibroblast and epithelial cells, and its independence from Smad2/Smad3.
  • Investigation of the role of Rac1 and Cdc42 in regulating TGF-beta-stimulated PAK2 activity.
  • Functional validation using dominant-negative PAK2 and morpholino antisense oligonucleotides.

Main Results:

  • TGF-beta receptor signaling activates PAK2 in mammalian cells.
  • PAK2 activation by TGF-beta was observed exclusively in fibroblast cultures, not epithelial cells, and was independent of Smad2/Smad3.
  • TGF-beta-induced PAK2 activity is modulated by Rac1 and Cdc42.
  • Inhibition of PAK2 activity prevented TGF-beta-induced morphological changes in fibroblasts.

Conclusions:

  • PAK2 activation represents a novel Smad-independent signaling pathway downstream of TGF-beta receptor.
  • This PAK2 pathway differentiates TGF-beta signaling, mediating growth stimulation in fibroblasts and potentially distinct responses in epithelial cells.
  • The findings reveal a key molecular mechanism underlying cell-type-specific responses to TGF-beta.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...